Update on clinical practice recommendations and new therapeutic modalities for treating anemia in patients with chronic kidney disease (Q80528081)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17591995%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Update on clinical practice recommendations and new therapeutic modalities for treating anemia in patients with chronic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17591995%20AND%20SRC:MED&resulttype=core&format=json

chronic renal insufficiency

1 January 2020

main subject

1 reference

Darren W Grabe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17591995%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17591995%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Health-System Pharmacy

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17591995%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17591995%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

13 Suppl 8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17591995%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

S8-14; quiz S23-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17591995%20AND%20SRC:MED&resulttype=core&format=json

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

Preference for monthly darbepoetin alfa dosing in patients with chronic kidney disease not receiving dialysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

Once-Monthly Administration of Darbepoetin Alfa for the Treatment of Patients with Chronic Heart Failure and Anemia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

Darbepoetin alfa administered once monthly maintains hemoglobin concentrations in patients with chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

An overview of the pharmacokinetic disposition of darbepoetin alfa

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

Darbepoetin alfa administered once monthly maintains haemoglobin levels in stable dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

Recent advances in erythropoietic agents in renal anemia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

HIF-1 as a target for drug development

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

Determination of VIT 45 (IND#63,243 - American Regent) removal by closed loop in vitro hemodialysis system

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

Delivery of an erythropoietin-Fc fusion protein by inhalation in humans through an immunoglobulin transport pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070182

31 March 2020

Identifiers

DOI

10.2146/AJHP070182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17591995%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference